Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas

International journal of radiation oncology, biology, physics

Volumn 54, Issue 3, 2002, Pages 842-854

  Grosu, Anca Ligia ^a   Feldmann, Horst ^b   Dick, Susanne ^a   Dzewas, Brigitte ^c   Nieder, Carsten ^a   Gumprecht, Hartmut ^d   Frank, Andreas ^e   Schwaiger, Markus ^c   Molls, Michael ^a   Weber, Wolfgang Andreas ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinik fu r Strahlentherapie Fulda   (Germany)

^c Nuklearmedizinische Klinik und Poliklinik   (Germany)

^d KLINIKUM BOGENHAUSEN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

123I methyl tyrosine; Brain gliomas; MRI; Radiotherapy; SPECT

Indexed keywords

3 IODO ALPHA METHYLTYROSINE; 3-IODO-ALPHA-METHYLTYROSINE; DIAGNOSTIC AGENT; METIROSINE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; EVALUATION; FEMALE; GLIOMA; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE PERIOD; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MALE; METHYLTYROSINES; MIDDLE AGED; NEOPLASM, RESIDUAL; POSTOPERATIVE PERIOD; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 18744399886     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02984-X     Document Type: Article

References (34)

1. T.N. Byrne Imaging of gliomas Semin Oncol 21 1994 162 171
2. K. Sartor MR imaging of the brain tumors Eur Radiol 9 1999 1047 1054
3. E. Galanis J.C. Buckner P. Novotny Efficacy of neuroradiological imaging, neurological examination, and symptoms status in follow-up assessment of patients with high-grade gliomas J Neurosurg 93 2000 201 207
4. P.J. Kelly C. Daumas-Duport D.B. Kispert Imaged-based stereotaxic serial biopsies in untreated intracranial glial neoplasm J Neurosurg 66 1987 865 874
5. P.J. Kelly C. Daumas-Duport B.W. Scheitauer Stereotactic histologic correlations of CT- and MRI-defined abnormalities in patients with glial neoplasms Mayo Clin Proc 62 1987 450 459
6. M.C. Chamberlain J.A. Murovic V.A. Levin Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas Neurology 38 1988 1371 13744
7. M. Mosskin K. Ericson T. Hindmarsh Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference Acta Radiol 30 1989 225 232
8. T. Ogawa F. Shishido I. Kanno Cerebral glioma Evaluation with methionine PET Radiology 186 1993 45 53
9. 11C-methionine and positron emission tomography Am J Neuroradiol 6 1985 505 514
10. 11C)-L-methionine uptake in cerebral gliomas A comparative study using SPECT and PET J Nucl Med 38 1997 517 522
11. 123I)iodo-alpha-methyl tyrosine and SPECT J Nucl Med 30 1989 110 112
12. 123I)iodo-alpha-methyl-tyrosine Competition with natural L-amino acids J Nucl Med 32 1991 1225 1228
13. W. Weber P. Bartenstein M.W. Gross Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors J Nucl Med 38 1997 802 808
14. T. Kuwert B. Woesler C. Morgenroth Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine J Nucl Med 39 1998 23 27
15. 123I)iodo-alpha-methyltyrosine SPET and (18F)fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up A comparative study with stereotactic biopsy Eur J Nucl Med 26 1999 144 151
16. U. Pietrzyk K. Herholz G. Fink An interactive technique for three-dimensional image registration Validation for PET, SPECT, MRI and CT brain studies J Nucl Med 35 1994 2011 2018
17. A.F. Thornton H.M. Sandler R.K.T. Haken The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms Int Radiat Oncol Biol Phys 24 1992 767 775
18. S.A. Leibel C.B. Scott J.S. Loeffler Contemporary approaches to the treatment of malignant gliomas with radiation therapy Semin Oncol 21 1994 198 219
19. A.L. Grosu H.J. Feldmann C. Albrecht Three-dimensional treatment planning of brain tumors Advantages of the method and clinical results Strahlenther Onkol 174 1998 7 13
20. A. Pirzkall T.R. McKnight E.E. Graves MR-spectroscopy guided target delineation for high-grade gliomas Int Radiat Oncol Biol Phys 50 2001 915 928
21. E.E. Graves S.J. Nelson D.B. Vigneron A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas Neurosurgery 46 2000 319 328
22. 11C) methionine uptake in brain tumors Initial results of a comparative study Eur J Nucl Med 27 2000 542 549
23. 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1998 1316 1322
24. B. Kaschten A. Stevenaert B. Sadzot Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 1998 778 785
25. H. de Wolde J. Pruim M.F. Mastik Proliferative activity in human brain tumors Comparison of histopathology and L-(1-(11)C)tyrosine PET J Nucl Med 38 1997 1369 1374
26. M. Sasaki Y. Kuwabara T. Yoshida A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxiglucose PET for the differentiation of astrocytic tumors Eur J Nucl Med 25 1998 1261 1269
27. D. Schmidt U. Gottwald K.J. Langen Eur J Nucl Med 28 2001 855 861
28. 123I)Iodo-l-alpha-methyltyrosine uptake and survival in patients with gliomas J Nucl Med 42 2001 1144 1150
29. A.L. Grosu W.A. Weber H.J. Feldmann PET and SPECT in three-dimensional treatment planning of brain gliomas H.J. Feldmann P. Kneschaurek M. Molls Three-dimensional radiation treatment Technological innovations and clinical results 2000 Karger Basel 97 105
30. G. Di Chiro Positron emission tomography using F-18 fluorodeoxyglucose in brain tumors A powerful diagnostic and prognostic tool Invest Radiol 22 1986 360 371
31. S. Goldmann M. Levivier B. Pirotte Regional glucose metabolism and histopathology of gliomas A study based on positron emission tomography-guided stereotactic biopsy Cancer 78 1996 1098 1106
32. M.W. Gross W. Weber H.J. Feldmann The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas Int J Radiat Oncol Biol Phys 41 1998 989 995
33. J.M. Hoffman New advances in brain tumor imaging Curr Opin Oncol 13 2001 148 153
34. 123I-alpha-methyl-tyrosine SPECT in 3-D radiation treatment planning of brain gliomas Int Radiat Oncol Biol Phys 47 2000 517 526